Newsroom Stories

The single-year health burden associated with physical intimate partner violence in the South American country of Columbia was $90.6 million, finds a new study from the Brown School at Washington University in St. Louis.

A mouse study led by Washington University School of Medicine suggests that combining SGLT2 inhibitors — a newer class of diabetes medications that lowers blood sugar — with older diabetes drugs may help to slow the progression of diabetic kidney disease.

Sheryl Mauricio, associate dean for student conduct and community standards, has been promoted to associate vice chancellor for student affairs, announced Anna Gonzalez, vice chancellor for student affairs.

Researchers at Washington University School of Medicine have found that although there have been steady increases in the number of people nationwide who die by suicide, such increases have slowed in states that have implemented Medicaid expansion.

Collaborative research from the labs of Daniel Giammar and Jeffrey Catalano finds a lack of available metals may be responsible for more nitrous oxide than previously thought.

New analysis of the Adolescent Brain Cognitive Development Study by Ryan Bogdan’s lab in Arts & Sciences finds no link to depression in children with prenatal exposure to selective serotonin reuptake inhibitors (SSRI) drugs.

At the Washington University Board of Trustees meeting May 6, numerous faculty members were appointed or promoted with tenure or granted tenure, with most taking effect July 1.

Washington University in St. Louis has joined SlaveVoyages, a collaborative digital initiative that compiles records related to the trans-Atlantic slave trade. William Acree, co-director of the Center for the Study of Race, Ethnicity & Equity (CRE²), says membership provides university faculty and students an opportunity to both benefit from and contribute to SlaveVoyages’ critical scholarship.

Federal district judges appointed by Republican presidents were found to be less likely to require mask wearing in the courtroom during the COVID-19 pandemic, finds a new study from the School of Law.

A study from the Washington University School of Medicine shows that treatment with the immunity boosting protein interleukin 7 (IL-7) after an infusion of genetically modified T cells causes the cancer-fighting CAR-T cells to grow in number and become more effective at killing tumor cells.